Proper peripheral myelination depends upon the balance between Schwann cell proliferation and differentiation programs. The serine/threonine kinase mTOR integrates various environmental cues to serve as a central regulator of cell growth, metabolism, and function. We report here that 
| I N T R O D U C T I O N
Myelination of axons is vital for rapid saltatory conduction of action potentials and effective sensorimotor integration. In the peripheral nervous system (PNS), Schwann cells (SCs) wrap large-caliber axons to form tightly compacted myelin sheaths. Defects in myelination lead to peripheral neuropathies such as Charcot-Marie-Tooth disease and congenital hypomyelinating neuropathy (Brennan, Bai, & Shy, 2015; Sanmaneechai et al., 2015; Scherer & Wrabetz, 2008; Warner, Garcia, & Lupski, 1999) .
Peripheral myelin formation requires SC expansion and differentiation, and the onset of myelination is linked to cell cycle exit (Atanasoski et al., 2006; Jessen & Mirsky, 2005) . Controlling the balance between SC proliferation and differentiation is critical for ensuring myelination proceeds properly. The TSC1/2-mTOR signaling axis regulates cell growth and differentiation by regulating protein translation (Laplante & Sabatini, 2009) . Various upstream signals, such as nutrients and growth factors, converge on the tumor suppressors TSC1 and TSC2, which form a complex that negatively regulates the mTOR pathway, and ultimately organismal growth and homeostasis (Inoki et al., 2002; Laplante & Sabatini, 2012) . Disruption of the TSC1/2 complex activates Rheb-GTPase and subsequent mTOR signaling through the mTORC1 and mTORC2 complexes. mTOR targets S6K and 4EBP1 control cell growth processes such as ribosomal biogenesis and cap-dependent protein translation (Hay & Sonenberg, SC growth and differentiation can be driven by extracellular molecules such as neuregulin I (NRG1) and laminin 211/GPR126, and intracellular signaling cascades including the Hippo and PI3K-AKT signaling pathways (D'Antonio et al., 2006; Deng et al., 2017; Ghidinelli et al., 2017; Herbert & Monk, 2017; Monk, Feltri, & Taveggia, 2015; Taveggia et al., 2005) . Activation of the PI3K-AKT pathway by axonal NRG1 acts upstream of mTOR, regulating SC migration, proliferation, and survival (Ma, Wang, Song, & Loeb, 2011; Maurel & Salzer, 2000; Yamauchi, Miyamoto, Chan, & Tanoue, 2008) . Balanced effects of cellcycle promoting effectors and inhibitors, such as CDK2 and p27, respectively, regulate SC lineage progression (Porrello et al., 2014; Tikoo et al., 2000) . In addition, mTOR signaling has also been implicated in regulation of the polo-like kinase (PLK) pathway (Nakashima et al., 2008; Renner et al., 2010) . PLKs are key regulators of cell cycle progression with established functions in cell cycle entry, mitosis, bipolar spindle formation, chromosome segregation, and cytokinesis (Barr, Sillje, & Nigg, 2004; Liu & Erikson, 2002; Tang, Erikson, & Liu, 2006) . mTORC1 is crucial for myelination in both central and peripheral nervous systems (Beirowski, Wong, Babetto, & Milbrandt, 2017; Bercury et al., 2014; Figlia, Gerber, & Suter, 2018; Lebrun-Julien et al., 2014; Norrm en et al., 2014; Sherman et al., 2012; Wahl et al., 2014) . Loss of mTOR leads to profound hypomyelination in the PNS (Sherman et al., 2012) , and, conversely, activation of mTOR through the loss of PTEN or activation of AKT promotes hypermyelination in the PNS (Domenech-Estevez et al., 2016; Goebbels et al., 2010; Maurel et al., 2000) .
Recent studies indicate that TSC1/2-mTOR signaling is a critical regulator of SC development and myelination in the PNS (Beirowski et al., 2017; Figlia et al., 2017) , however, the precise mechanisms whereby mTOR controls SC growth and the transition from proliferation to differentiation are not yet fully understood.
Here, we show that sustained activation of mTOR signaling by Tsc1 ablation during early developmental stages increased SC proliferation and delayed radial sorting, causing hypomyelination in the PNS, while Tsc1 ablation in myelinating SCs at postnatal stages promoted myelin overgrowth and outfoldings. We further found that sustained signaling through the mTOR pathway led to activation of downstream PLK-mediated signaling. mTOR attenuation or pharmacological inhibition of PLK1/2 promotes SC differentiation and partially rescued myelination defects in Tsc1-mutant sciatic nerves. Our data suggest that the TSC1-mTOR-PLK axis maintains the homeostasis of SC proliferation and myelination in a stage-specific manner.
| MATERIALS A ND METHODS

| Animals
The floxed Tsc1 (Tsc1 ) and Tsc1-iKO offspring. Animals of both sexes were used in the study and heterozygous littermates were used as controls unless otherwise indicated. The mouse strains used in this study were generated and maintained on a mixed C57Bl/6;129Sv background and housed in a vivarium with a 12-hr light/dark cycle. All animal use protocols and studies were approved by the Institutional Animal Care and Use Committee of the Cincinnati Children's Hospital Medical Center.
| Histology and electron microscopy
The sciatic nerves of mice at defined ages were dissected and fixed overnight in 4% paraformaldehyde and processed for cryo-sectioning or fiber analyses. Tissue processing was performed essentially as described previously (Wu et al., 2016) . Briefly, mice were deeply anesthetized with ketamine/xylazine, perfused with 0.1 M cacodylate, followed by 2.5% paraformaldehyde/2.5% glutaraldehyde in 0.1 M cacodylate (pH 7.2). Sciatic nerves were dissected, post-fixed in 1% OsO 4 , dehydrated through a graded ethanol series, infiltrated in propylene oxide, and embedded in resin. Semi-thin sections were stained with toluidine blue, and ultrathin sections were stained with lead citrate.
| Immunohistochemistry and immunoblotting
Cryosections (8-lm thick) were permeabilized and blocked in blocking buffer (0.3% Triton X-100 and 5% normal donkey serum in PBS) for 1 hr at room temperature and overlaid with primary antibodies overnight at 48C. Antibodies used in the study were goat anti-Sox10 (Santa umd.edu). TopHat output data were then analyzed by Cufflinks to calculate FPKM values for known transcripts in the mouse genome reference and to test for differences in expression between Tsc1-cKO and control transcriptomes. Heatmap of gene differential expression was generated using Gene Cluster and Java Treeview. Gene ontology functional classifications were performed using DAVID (http://david.abcc.
ncifcrf.gov) and Ingenuity Pathway Analysis.
| Cell cycle analysis
One million purified rat Schwann cells per group were seeded onto 10 cm poly-L-lysine (PLL)-coated dishes and allowed to attach overnight.
Cells were then treated with DMSO or 100 nM BI-2536 for 24 hr. Cells were collected, fixed using cold 70% ethanol and stained with 7-AAD (7-amino actinomycin D) (Southern Biotech, Birmingham, AL, USA).
Stained cells were run on a BD LSR II (Franklin Lakes, NJ, USA) flow cytometer and gated on forward and side scatter. Cell cycle distributions were computed using FlowJo platform (https://www.flowjo.com/).
| Statistical analysis
All analyses were done using Microsoft Excel or GraphPad Prism 6.00
(www.graphpad.com). Quantifications were performed from at least three independent experiments. Data are shown as means 6 SEM. Statistical significance (p < .05) was determined using two-tailed Student's t tests unless otherwise indicated. Figure   1g ,h). Since Sox2 expression reflects the SC progenitor state and subsides as differentiation commences, these observations suggest that
Tsc1 ablation in SC lineage progenitors inhibits the maturation process.
| Lack of TSC1 elevates SC proliferation and blocks the differentiation process
The increase of Sox2 proliferating cells in the S phase within two hours pulse-chasing, while
Ki67 labels all cycling cells. Compared with the control nerves, the percentages of Ki67-expressing and BrdU-labeled proliferative SCs were significantly higher in Tsc1-mutant sciatic nerves than in controls . This indicates that the activation of mTOR observed in the absence of TSC1 enhances SC proliferation.
At P10, control SCs had advanced to the myelinating phase, however, the percentage of Krox20 1 mature SCs was significantly reduced from 48% 6 2.0% in controls to 23% 6 1.1% in Tsc1-cKO sciatic nerves (Figure 2e ,f). These data suggest that Tsc1 ablation leads to an increase in proliferative SCs and a reduction in SC differentiation.
| TSC1-deficient mutants exhibit peripheral myelination defects
To examine the extent of myelination in Tsc1-cKO mice, we performed ultrastructural analysis at different stages by electron microscopy. At P7, SCs from control sciatic nerves had completed radial sorting and were present at a 1:1 ratio with axons; however, in Tsc1-cKO sciatic nerves, unmyelinated large axon bundles were detected (Figure 3a) , suggesting a radial sorting defect in mutants. In contrast to control sciatic nerves where 90% of axons were myelinated at P7, only 6% of axons were myelinated in Tsc1-cKO sciatic nerves (Figure 3a-c) , indicating a defect in initiation of myelination in mutants (Figure 3a,c) .
At P30, essentially all large diameter axons were myelinated in the control sciatic nerves. At this stage, 90% of axons were myelinated in the Tsc1-cKO mutants, and the majority of SCs were present in a 1:1 ratio to axons (Figure 3d ). However, we detected a substantial population of SCs that were not associated with axons and were not myelinating (Figure 3d ,e), suggesting that these SCs are immature. The thickness of myelin sheath defined by the g-ratio (the ratio between inner axon diameter and outer diameter of the myelinated sheath) of sciatic nerve fibers (Hildebrand & Hahn, 1978) , however, was significantly lower in Tsc1-cKO mice than in control mice (Figure 3f ).
At P60, the number of immature SCs that were not associated with axons in Tsc1-cKO mice was diminished, however, the percentage of unmyelinated axons was still higher in Tsc1-mutant sciatic nerves than controls (Figure 3g ,h). The thickness of myelin sheath defined by the gratio of sciatic nerve fibers remained lower in Tsc1-cKO mice (Figure 3i ).
Together, these data showed that the Tsc1-cKO mice have a hypomyelinating phenotype during peripheral nerve development, indicating that ablation of Tsc1 delays SC differentiation and myelination processes.
| Myelin deficiency in Tsc1-cKO mice is dependent on mTOR signaling
Given that TSC1 is an upstream negative regulator of mTOR signaling ;Cnp1-Cre; Sherman et al., 2012) , suggesting that mTOR is critical for normal SC myelination.
Together, our data suggest that dosage-dependent and balanced levels of TSC1-mTOR signaling is critical for proper SC differentiation and myelinogenesis.
3.5 | TSC1 loss in mature SCs leads to redundant myelin formation
To examine whether Tsc1 deficiency leads to sustained myelination defects in Tsc1-cKO mutants, we analyzed the myelin ultrastructure in adulthood. The percentage of unmyelinated axons in the Tsc1-mutant 
| Tsc1 ablation in SC progenitors upregulates cell cycle regulators
To determine the downstream mediators of TSC1-mTOR signaling involved in SC proliferation and differentiation, we performed transcriptome profiling of control and Tsc1-cKO sciatic nerves at P7, which contain both proliferating and differentiating SCs. Gene ontology analysis revealed that differentially expressed genes were overrepresented for cell cycle, lipid biosynthesis, and myelination ( Figure 6a ). Downregulated genes in Tsc1-cKO nerves were associated with SC differentiation, myelination and lipid biosynthesis programs (Svaren & Meijer, 2008) , while upregulated genes were linked to cell cycle, cell proliferation and mitosis (Figure 6b ). This is consistent with the aberrant increase of cell proliferation and the dysmyelination phenotype in Tsc1-cKO mice.
We further identified an altered gene cluster related to cell proliferation that is overrepresented in the Polo-like kinase (PLK) pathway, cell-cycle regulation, and G1/S checkpoint signaling (Figure 6b ). 
| Tsc1 ablation-induced hypomyelination is dependent on polo-like kinase signaling
To address how expression of Plk1 changes during sciatic nerve development, we performed qRT-PCR to examine the Plk1 mRNA levels at after nerve injury (Beirowski et al., 2017; Figlia et al., 2017) . In contrast to mice in which Tsc1 was ablated at P0 using the Cre system, which exhibit minor developmental defects in sciatic nerves (Beirowski et al., 2017) , in the present study we found that mice in which Tsc1 was deleted in SC precursors using Dhh-Cre expressed at E12.5 exhibited extensive hyperproliferation of immature SCs in the developing nerves.
Dhh-Cre expression begins one day earlier than that of P0-Cre (Feltri et al., 1999; Jaegle et al., 2003) , which could account for this discrep-
ancy. This suggests that TSC1-mediated regulation of SC proliferation is important at this early stage of immature SC development and that timing of mTOR activation is critical for SC expansion, in keeping with data from others (Figlia et al., 2017) . In Tsc1-cKO mutants, SC over- In the central nervous system, sustained activation of mTOR signaling leads to ER stress and oligodendrocyte cell death, whereas in peripheral nerves, despite the increase in ER stress responses (Supporting Information Figure S2 ), excessive mTOR signaling activation promotes proliferation of immature SCs unchecked by apoptosis. Although the molecular mechanisms underlying distinct phenotypes in the central and peripheral nervous systems remain to be elucidated, elevation of adaptive responses mediated by p-eIF2a (Jiang et al., 2016; Way et al., 2015) in Tsc1-mutant SCs (Supporting Information Figure S2 ) and strong upregulation of the SC proliferative program may contribute to SC survival.
| TSC1-mTOR signaling activates PLK to promote SC proliferation
Although the recent studies focus on SC myelination (Beirowski et al., 2017; Figlia et al., 2017) , the molecular mechanisms underlying TSC1 function in SC proliferation have not been fully defined. Zacharek et al., 2005) . mTORC1 activity appears to activate S6K to negatively regulate Krox20, a key SC regulator, to forestall the onset of SC myelination (Figlia et al., 2017) . We observed an increase in the proliferation of immature SCs and in expression of p-S6K and p-4E-BP1 in Tsc1-cKO mutants at early developmental stages, when SCs undergo proliferation. The attenuation of mTOR activity in Tsc1-cKO;mTOR f/1 mice decreased SC proliferation and partially restored the number of myelinated fibers, consistent with a recent study involving treatment of Tsc1 fl/fl ;P0-Cre mice with rapamycin, a pharmacological mTOR inhibitor (Beirowski et al., 2017; Figlia et al., 2017) . These observations suggest that the SC hyperproliferation and differentiation block observed upon ablation of
Tsc1 is mediated through mTOR activity. 
